,
,
, , p.61
,
,
,
,
,
, p = 0,43) et à J8, pp.68-96
, Si on observe l'amylase maximale, quel que soit le jour du dosage, la médiane dans le groupe FA était à 100 [54; 1397] U/L, significativement plus haute que dans le groupe sans fistule, p.40
, , p.1
, Ainsi un seuil d'amylase à 24 U/L en post-opératoire, peu importe le jour du dosage, permettait de prédire la survenue d'une FA avec une spécificité de 78% et une sensibilité de 82%. La CRP à J4 (figure 11B)
Adenocarcinoma of the middle third of the esophagus arising from ectopic gastric mucosa, J Thorac Surg, vol.37, issue.3, pp.398-403, 1959. ,
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012, Int J Cancer, vol.136, issue.5, pp.359-86, 2015. ,
Worldwide incidence, mortality and time trends for cancer of the oesophagus, Eur J Cancer Prev, vol.26, issue.2, pp.107-125, 2017. ,
,
, Cancer incidence and mortality in France over the 1980-2012 period: Solid tumors. Rev DÉpidémiologie Santé Publique, vol.62, pp.95-108, 2014.
Esophageal Cancer, N Engl J Med, vol.12, 2003. ,
,
, Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control CCC, vol.11, pp.231-239, 2000.
Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review ,
, , vol.23, p.12504, 2018.
CagA-Positive Strains of Helicobacter pylori May Protect Against Barrett's Esophagus, vol.95, p.6, 2000. ,
,
, The Association Between Barrett's Esophagus and Helicobacter pylori Infection: A Meta-Analysis: Association Between Barrett's Esophagus and Helicobacter pylori Infection
, Helicobacter, vol.17, issue.3, pp.163-75, 2012.
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, Lancet Oncol ,
Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia ,
, JAMA J Am Med Assoc, vol.265, issue.10, p.1287, 1991.
Management of cancer risk in Barrett's esophagus: Cancer in Barrett's esophagus, J Gastroenterol Hepatol, vol.26, issue.10, pp.1485-92, 2011. ,
The development and validation of an endoscopic grading system for Barrett's esophagus: the ,
, , vol.131, pp.1392-1401, 2006.
Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy, vol.49, pp.191-199, 2017. ,
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag, vol.3, pp.1035-145, 2007. ,
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis ,
, Gastrointest Endosc, vol.67, issue.3, pp.394-402, 2008.
,
, Retinoic acid-induced glandular differentiation of the oesophagus, Gut, vol.56, issue.7, pp.906-923, 2007.
Update on the epidemiology of gastrooesophageal reflux disease: a systematic review, Gut, vol.63, issue.6, pp.871-80, 2014. ,
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N Engl J Med, vol.340, issue.11, pp.825-856, 1999. ,
Role of endoscopy in GERD, Gastroenterol Clin North Am, 2014. ,
The association between gastroesophageal reflux disease and obesity, Am J Gastroenterol, vol.103, issue.8, pp.2111-2133, 2008. ,
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies, Br J Cancer, vol.116, issue.7, pp.951-960, 2017. ,
The Epidemiology of Esophageal Adenocarcinoma, Gastroenterology, vol.154, issue.2, pp.390-405, 2018. ,
Influence of obesity on the risk of esophageal disorders, Nat Rev Gastroenterol Hepatol, vol.8, issue.6, pp.340-347, 2011. ,
Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project, BMC Cancer, vol.14, p.103, 2014. ,
,
, Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.14, issue.10, pp.1412-1419, 2016.
Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium, J Natl Cancer Inst, vol.102, issue.17, pp.1344-53, 2010. ,
Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use, Clin Epigenetics, vol.8, p.111, 2016. ,
Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis, J Natl Cancer Inst, 2017. ,
Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study, Br J Nutr, vol.115, issue.2, pp.342-50, 2016. ,
,
, Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults, JAMA Intern Med, vol.176, issue.6, pp.816-841, 201601.
No further increase in the incidence of esophageal adenocarcinoma in Sweden, Int J Cancer, vol.129, issue.2, pp.513-519, 2011. ,
Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.23, issue.6, pp.997-1006, 2014. ,
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5, Eur J Cancer, vol.51, issue.15, pp.2144-57, 2015. ,
Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study, Eur J Cancer Prev, vol.26, pp.24-31, 2017. ,
Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology, vol.154, pp.421-457, 2018. ,
Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians, Ann Intern Med, vol.157, issue.11, p.808, 2012. ,
EAES recommendations for the management of gastroesophageal reflux disease, Surg Endosc, 2014. ,
Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidencebased consensus, Am J Gastroenterol, vol.101, issue.8, pp.1900-1920, 2006. ,
Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants, Gastroenterology, vol.154, issue.5, pp.1273-1281, 2018. ,
Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus. Gastroenterology, 2013. ,
,
Diagnosis and Management of Barrett's Esophagus, Am J Gastroenterol, vol.111, issue.1, pp.30-50, 2016. ,
Emerging optical methods for surveillance of Barrett's oesophagus, Gut, vol.64, issue.11, pp.1816-1839, 2015. ,
A Systematic Review of Esophageal ,
, MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus, Dig Dis Sci, 2016.
Nonendoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic, Gut, vol.58, issue.11, pp.1451-1460, 2009. ,
,
, Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study, BMJ, vol.341, p.4372, 2010.
,
, Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma: Ann Surg, 2015.
A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease, Am J Gastroenterol, vol.104, issue.6, pp.1533-1542, 2009. ,
AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg, vol.6, pp.119-149, 2017. ,
Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer, J Thorac Oncol ,
A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma ,
, Gut, vol.49, issue.4, pp.534-543, 2001.
Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States ,
, Gastrointest Endosc, vol.86, issue.4, pp.600-607, 2017.
,
, High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas, Endoscopy, vol.38, issue.2, pp.149-56, 2006.
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline -Updated, Endoscopy, vol.49, issue.07, pp.695-714, 2017. ,
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans, Ann Thorac Surg, vol.98, issue.3, pp.1136-1137, 1999. ,
,
Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals, Dis Esophagus Off J Int Soc Dis Esophagus, vol.29, issue.8, pp.913-922, 2016. ,
,
Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis, J Cardiothorac Surg, vol.9, p.78, 2014. ,
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients, Ann Surg, vol.232, issue.3, pp.353-61, 2000. ,
Oesophagogastric junction adenocarcinoma: which therapeutic approach?, Lancet Oncol, vol.12, issue.3, pp.296-305, 2011. ,
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ?, Ann Oncol, vol.27, issue.suppl_5, pp.50-57, 2016. ,
,
, Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer
, J Natl Cancer Inst, vol.106, issue.7, 2014.
,
, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncol, vol.12, issue.7, pp.681-92, 2011.
,
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial, Lancet Oncol, vol.16, issue.9, pp.1090-1098, 2015. ,
,
, Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer, J Clin Oncol, vol.27, issue.30, pp.5062-5069, 2009.
,
, Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial, Lancet Lond Engl, vol.393, pp.1948-57, 10184.
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.27, issue.5, pp.38-49, 2016. ,
,
, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus, N Engl J Med, vol.326, issue.24, pp.1593-1601, 1992.
Assessment of different prognostic scores for early postoperative outcomes after esophagectomy, Chir Buchar Rom, vol.109, issue.4, pp.480-485, 1990. ,
Cancer Treatment in the Elderly, J Am Coll Surg, 1998. ,
, United Nations, Department of Economic and Social Affairs, vol.187, pp.427-435
, World Population Ageing, 2013.
Mortality after Esophagectomy: Risk Factor Analysis, World J Surg, vol.21, issue.6, pp.599-604, 1997. ,
Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg, vol.391, pp.455-60, 2006. ,
Cancer of the esophagus and cardia: does age influence treatment selection and surgical outcomes?, J Am Coll Surg, vol.187, issue.4, pp.345-51, 1998. ,
Clinical outcome and survival after esophagectomy for carcinoma in elderly patients, Dis Esophagus Off J Int Soc Dis Esophagus, vol.16, issue.2, pp.90-93, 2003. ,
Esophagectomy for cancer in octogenarians: should we do it? Langenbecks Arch Surg, vol.402, pp.539-584, 2017. ,
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer, Br J Surg, vol.85, issue.6, pp.840-844, 1998. ,
Factors Affecting Postoperative Course and Survival After En Bloc Resection for Esophageal Carcinoma, Ann Thorac Surg ,
Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study, BMJ, vol.327, issue.7425, pp.1192-1199, 2003. ,
Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 1982. ,
POSSUM: a scoring system for surgical audit, Br J Surg, vol.78, issue.3, pp.355-60, 1991. ,
, Prise en charge du coronarien opéré en chirurgie non cardiaque. Ann Fr Anesth Réanimation, vol.30, pp.5-29, 2011.
,
, Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation, vol.100, pp.1043-1052, 1999.
,
, Cardiovasc Surg, vol.121, issue.6, pp.1064-1072, 2001.
, Coebergh J
Surgical Mortality in Patients With Esophageal Cancer: Development and Validation of a Simple Risk Score, J Clin Oncol, vol.24, issue.26, pp.4277-84, 2006. ,
Revised ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Implications for preoperative clinical evaluation, Minerva Anestesiol, vol.81, issue.2, pp.226-259, 2015. ,
,
, Br J Surg, vol.86, issue.12, pp.1583-1590, 1999.
Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer, Eur J Surg Acta Chir, vol.164, issue.8, pp.581-587, 1998. ,
Pulmonary complications after esophagectomy, Ann Thorac Surg, vol.73, issue.3, pp.922-928, 2002. ,
Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. Cochrane Anaesthesia, Critical and Emergency Care Group, editor. Cochrane Database Syst Rev, 2015. ,
,
,
, Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer: Inspiratory muscle training before surgery for oesophageal cancer, Br J Surg, vol.105, issue.5, pp.502-513, 2018.
French clinical guidelines on perioperative nutrition. Update of the 1994 consensus conference on perioperative artificial nutrition for elective surgery in adults, J Visc Surg, vol.149, issue.5, pp.325-336, 2012. ,
Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer, World J Surg, vol.31, issue.11, pp.2160-2167, 2007. ,
,
, Thorac Cardiovasc Surg, vol.134, issue.5, pp.1284-91, 2007.
,
Is there a place for esogastric cancer surgery in cirrhotic patients?, Ann Surg Oncol, vol.15, issue.3, pp.680-682, 2008. ,
Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients, Ann Surg, 1987. ,
Patient and perioperative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program, pp.2005-2008 ,
, Gastrointest Surg Off J Soc Surg Aliment Tract, vol.14, issue.10, pp.1492-501, 2010.
Anesthésie-réanimation en chirurgie du cancer de l'oesophage, vol.14, 2018. ,
Riskadjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM, Br J Surg, vol.91, issue.3, pp.288-95, 2004. ,
Prediction of major pulmonary complications after esophagectomy, Ann Thorac Surg, vol.91, issue.5, pp.1500-1501, 2011. ,
Risk Assessment Using a Novel Score to Predict Anastomotic Leak and Major Complications after Oesophageal Resection, J Gastrointest Surg, vol.16, issue.6, pp.1083-95, 2012. ,
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis, Ann Surg, vol.265, issue.3, pp.481-91, 2017. ,
Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer: Ann Surg, vol.263, pp.712-720, 2016. ,
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial, Lancet Oncol, vol.7, issue.8, pp.644-51, 2006. ,
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus, N Engl J Med, vol.347, issue.21, pp.1662-1671, 2002. ,
Comparative Perioperative Outcomes by Esophagectomy Surgical Technique, J Gastrointest Surg ,
, , 2019.
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial, Lancet Lond Engl, vol.379, issue.9829, pp.1887-92, 2012. ,
Healthrelated Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial, 111. van der Sluis PC, vol.13, p.230, 2012. ,
Optimum Lymphadenectomy for Esophageal Cancer: Ann Surg, vol.251, pp.46-50, 2010. ,
Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study, BMJ Open, vol.6, issue.8, p.12624, 2016. ,
Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction: Ann Surg, 2016. ,
Impact of Hospital Volume on Operative Mortality for Major Cancer Surgery ,
, , vol.280, p.1747, 1998.
Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review, Dis Esophagus [Internet], issue.5, p.31, 2018. ,
Perioperative Risk Factors for Anastomotic Leakage After Esophagectomy, Chest, vol.128, issue.5, pp.3461-3467, 2005. ,
The evolution of fast track protocols after oesophagectomy, J Thorac Dis, vol.11, issue.S5, pp.675-84, 2019. ,
A new postoperative pain management (intravenous acetaminophen: Acelio®) leads to enhanced recovery after esophagectomy: a propensity score-matched analysis, Surg Today, vol.48, issue.5, pp.502-511, 2018. ,
,
, Ketorolac and Other NSAIDs Increase the Risk of Anastomotic Leakage After Surgery for GEJ Cancers: a Cohort Study of 557 Patients, J Gastrointest Surg, vol.22, issue.4, pp.587-94, 2018.
Perioperative Fluid Management for Pulmonary Resection Surgery and Esophagectomy, Semin Cardiothorac Vasc Anesth, vol.18, issue.1, pp.36-44, 2014. ,
Assessing fluid responsiveness during open chest conditions, Br J Anaesth, vol.94, issue.3, pp.318-341, 2005. ,
A systematic review of pulse pressure variation and stroke volume variation to predict fluid responsiveness during cardiac and thoracic surgery, J Clin Monit Comput, vol.31, issue.4, pp.677-84, 2017. ,
Stroke volume variation as a predictor of intravascular volume depression and possible hypotension during the early postoperative period after esophagectomy, Ann Surg Oncol, vol.16, issue.5, pp.1371-1378, 2009. ,
Evaluation of respiratory status in patients after thoracic esophagectomy using PiCCO system ,
, Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia, vol.14, issue.5, pp.283-291, 2008.
,
, Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patients, BMC Surg, 2017.
, Jan, vol.13, issue.1, p.6
The Risk of Acute Kidney Injury from Fluid Restriction and Hydroxyethyl Starch in Thoracic Surgery, 2016. ,
Goal-directed therapy during transthoracic oesophageal resection does not improve outcome: Randomised controlled trial, Eur J Anaesthesiol, vol.36, issue.2, pp.153-61, 2019. ,
The Effect of Perfusion Pressure on Gastric Tissue Blood Flow in an Experimental Gastric Tube Model: Anesth Analg, vol.110, pp.541-547, 2010. ,
,
, Br J Anaesth, vol.112, issue.5, pp.920-928, 2014.
Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery, Crit Care Lond Engl, vol.13, issue.2, p.41, 2009. ,
Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study, Anesthesiology, vol.105, issue.5, pp.911-920, 2006. ,
Setting Individualized Positive End-Expiratory Pressure Level with a Positive End-Expiratory Pressure Decrement Trial After a Recruitment Maneuver Improves Oxygenation and Lung Mechanics During One-Lung Ventilation, Anesth Analg, vol.118, issue.3, pp.657-65, 2014. ,
The effect of formalizing enhanced recovery after esophagectomy with a protocol: Enhanced recovery for esophagectomy, Dis Esophagus, vol.28, issue.6, pp.567-73, 2015. ,
Enhanced Recovery for Esophagectomy: A Systematic Review and Evidence-Based Guidelines, Ann Surg, vol.259, issue.3, pp.413-444, 2014. ,
Direct Oral Feeding Following Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial ,
, Ann Surg, 2019.
Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study, Ann Surg Oncol ,
Minimally invasive esophagectomy: outcomes in 222 patients, Ann Surg, 2003. ,
Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery, Br J Surg, 2001. ,
Outcomes After Minimally Invasive Esophagectomy: Review of Over 1000 Patients, Ann Surg, 2012. ,
,
, Ann Surg Oncol, vol.21, issue.8, pp.2573-2582, 2014.
Comparison between esophagography and chest computed tomography for evaluation of leaks after esophagectomy and gastric pull-through, J Thorac Imaging, vol.28, issue.2, pp.121-129, 2013. ,
Routine endoscopy to detect anastomotic leakage after esophagectomy, Ann Thorac Surg, vol.95, issue.1, pp.292-300, 2013. ,
Treatment of anastomotic leaks with metallic stent after esophagectomies: Stent anastomotic leaks esophagectomy, Dis Esophagus, vol.29, issue.1, pp.86-92, 2016. ,
Drain Amylase Levels Are an Adjunct in Detection of Gastrojejunostomy Leaks after Roux-en-Y Gastric Bypass, J Am Coll Surg, vol.208, issue.5, pp.881-885, 2009. ,
Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection. Cochrane Database Syst Rev, 2017. ,
, Apr, p.12009
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Ann Surg Oncol, 2010. ,
, Acute Respiratory Distress Syndrome: The Berlin Definition, JAMA, 2012.
, , p.307
Predictors of operative death after oesophagectomy for carcinoma, Br J Surg, vol.92, issue.8, pp.1029-1062, 2005. ,
Morbidity and mortality after esophagectomy for esophageal carcinoma: a risk analysis, World J Surg Oncol, vol.3, issue.1, p.37, 2005. ,
A review of ASA physical status -historical perspectives and modern developments, Anaesthesia, vol.74, issue.3, pp.373-382, 2019. ,
Impact of postoperative complications on outcomes after oesophagectomy for cancer, Br J Surg, 2018. ,
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis ,
, Ann Thorac Surg, vol.102, issue.2, pp.416-439, 2016.
Risk and Complication Management in Esophageal Cancer Surgery: A Review of the Literature, Thorac Cardiovasc Surg, vol.64, issue.07, pp.596-605, 2015. ,
Impact of Different Crystalloid Volume Regimes on Intestinal Anastomotic Stability: Ann Surg, 2009. ,
, Feb, vol.249, issue.2, pp.181-186
Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients, Ann Surg, vol.266, issue.5, pp.814-835, 2017. ,
,
, Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study, 2019.
Methods of esophagogastric anastomoses following esophagectomy for cancer: A systematic review, J Surg Oncol, vol.101, issue.6, pp.527-560, 2010. ,
Drain amylase aids detection of anastomotic leak after esophagectomy, vol.7, p.8, 2016. ,
Impact of hospital volume on risk-adjusted mortality following oesophagectomy in Japan: Hospital volume and mortality following oesophagectomy, Br J Surg, vol.103, issue.13, pp.1880-1886, 2016. ,
Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis, Gut, 2014. ,
Factors Associated with Postoperative Pulmonary Morbidity After Esophagectomy for Cancer, Ann Surg Oncol ,
Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction, J Clin Oncol, vol.32, issue.27, pp.2983-90, 2014. ,
Perioperative risk factors for acute lung injury after elective oesophagectomy, Br J Anaesth, 2001. ,
Reducing hospital morbidity and mortality following esophagectomy, Ann Thorac Surg, 2004. ,
Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality, J Thorac Cardiovasc Surg, vol.126, issue.4, pp.1162-1169, 2003. ,
Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients, Surg Today, vol.44, issue.5, pp.839-886, 2014. ,
A decade of experience with transthoracic and transhiatal esophagectomy, Am J Surg, vol.183, issue.2, pp.162-169, 2002. ,
Chylothorax following oesophagogastrectomy for malignant disease, Eur J Cardiothorac Surg, vol.14, issue.5, pp.460-466, 1998. ,
The Clinical and Economic Costs of Delirium After Surgical Resection for Esophageal Malignancy: Ann Surg, 2013. ,
Adjunctive Haloperidol Prophylaxis Reduces Postoperative Delirium Severity and Duration in At-Risk Elderly Patients: The Neurologist, vol.14, pp.134-141, 2008. ,
Size of recurrent laryngeal nerve as a new risk factor for postoperative vocal cord paralysis, Dis Esophagus [Internet], issue.6, p.31, 2018. ,
,
Clinical applications of amylase: Novel perspectives, Surgery, vol.160, issue.1, pp.26-37, 2016. ,
Increasing levels of saliva alpha amylase in electrohypersensitive (EHS) patients, Int J Radiat Biol, vol.93, issue.8, pp.841-849, 2017. ,
URL : https://hal.archives-ouvertes.fr/ineris-01863166
Prognostic Value of Chest-Tube Amylase Versus C-Reactive Protein as Screening Tool for Detection of Early Anastomotic Leaks After Ivor Lewis Esophagectomy, J Laparoendosc Adv Surg Tech, 2019. ,
, Feb, vol.29, issue.2, pp.192-199
Diagnostic value of drain amylase for detecting intrathoracic leakage after esophagectomy, World J Gastroenterol, vol.21, issue.30, p.9118, 2015. ,
, Serment d'hippocrate
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux. Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire
, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément. Je préserverai l'indépendance nécessaire à l'accomplissement de ma mission. Je n'entreprendrai rien qui dépasse mes compétences
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, Admis dans l'intérieur des maisons, mes yeux ne verront pas ce qui s'y passe, ma langue taira les secrets qui me seront confiés et mon état ne servira pas à corrompre les moeurs ni à favoriser le crime. Respectueux et reconnaissant envers mes MAÎTRES, En présence des Maîtres de cette FACULTE et de mes chers CONDISCIPLES, je promets et je jure d'être fidèle aux lois de l
, Que les HOMMES m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couvert d'OPPROBRE et méprisé de mes confrères si j'y manque